(Q34125185)

31 July 2017

1 reference

title

H1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects (English)

1 reference

31 July 2017

1 reference

R Leurs

1

1 reference

31 July 2017

M K Church

series ordinal

2

1 reference

31 July 2017

M Taglialatela

series ordinal

3

1 reference

31 July 2017

language of work or name

1 reference

1 April 2002

1 reference

Clinical & Experimental Allergy

31 July 2017

1 reference

31 July 2017

32

1 reference

31 July 2017

4

1 reference

31 July 2017

489-498

1 reference

Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins

31 July 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.0954-7894.2002.01314.X

The two-state model of receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0954-7894.2002.01314.X

Inverse agonism of histamine H2 antagonist accounts for upregulation of spontaneously active histamine H2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0954-7894.2002.01314.X

High constitutive activity of native H3 receptors regulates histamine neurons in brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0954-7894.2002.01314.X

Constitutive activity of the histamine H(1) receptor reveals inverse agonism of histamine H(1) receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0954-7894.2002.01314.X

Expression of histamine receptors in nasal epithelial cells and endothelial cells--the effects of sex hormones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0954-7894.2002.01314.X

Postnatal expression of H1-receptor mRNA in the rat brain: correlation to L-histidine decarboxylase expression and local upregulation in limbic seizures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0954-7894.2002.01314.X

Histamine H1 receptors in complex partial seizures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0954-7894.2002.01314.X

Inhibition of histamine release from human lung in vitro by antihistamines and related drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0954-7894.2002.01314.X

In vitro effects of H1-antihistamines on histamine and PGD2 release from mast cells of human lung, tonsil, and skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0954-7894.2002.01314.X

Divalent cation dependence of the inhibition by phenothiazines of mediator release from mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0954-7894.2002.01314.X

Effects of the anti-allergics astemizole and norastemizole on Fc epsilon RI receptor-mediated signal transduction processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0954-7894.2002.01314.X

Structure-activity relationships of astemizole derivatives for inhibition of store operated Ca2+ channels and exocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0954-7894.2002.01314.X

The effect of cetirizine and loratadine on codeine-induced histamine release in human skin in vivo assessed by cutaneous microdialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0954-7894.2002.01314.X

Inhibition of chemiluminescence in granulocytes and alveolar macrophages by azelastine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0954-7894.2002.01314.X

Action of azelastine on intracellular Ca2+ in cultured airway smooth muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0954-7894.2002.01314.X

Inhibitory effect of oral cetirizine on in vivo antigen-induced histamine and PAF-acether release and eosinophil recruitment in human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0954-7894.2002.01314.X

The NF-kappa B and I kappa B proteins: new discoveries and insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0954-7894.2002.01314.X

Cetirizine counter-regulates interleukin-8 release from human epithelial cells (A549)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0954-7894.2002.01314.X

Hypothetical mechanisms of action of an H1-antihistamine in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0954-7894.2002.01314.X

Loratadine reduces the expression of ICAM-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0954-7894.2002.01314.X

Topical ocular levocabastine reduces ICAM-1 expression on epithelial cells both in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0954-7894.2002.01314.X

Nedocromil sodium and levocabastine reduce the symptoms of conjunctival allergen challenge by different mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0954-7894.2002.01314.X

Effects of capsaicin, bradykinin and prostaglandin E2 in the human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0954-7894.2002.01314.X

Effects of H1 antagonists on the cutaneous vascular response to histamine and bradykinin: a study using scanning laser Doppler imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0954-7894.2002.01314.X

Human skin mast cells: in vitro and in vivo studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0954-7894.2002.01314.X

Mechanisms of mediator release from human skin mast cells upon stimulation by the bradykinin analog, [dArg0-Hyp3-dPhe7]bradykinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0954-7894.2002.01314.X

Ketotifen inhibits the cutaneous but not the airway responses to platelet-activating factor in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0954-7894.2002.01314.X

Platelet-activating factor induces histamine release from human skin mast cells in vivo, which is reduced by local nerve blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0954-7894.2002.01314.X

Structural and functional aspects of G protein-coupled receptor oligomerization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0954-7894.2002.01314.X

G-protein-coupled receptors function as oligomers in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0954-7894.2002.01314.X

Involvement of the amino terminus of the B(2) receptor in agonist-induced receptor dimerization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0954-7894.2002.01314.X

AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0954-7894.2002.01314.X

Cardiotoxic effect with convulsions in terfenadine overdose

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0954-7894.2002.01314.X

Risk of torsades de pointes with non-cardiac drugs. Doctors need to be aware that many drugs can cause qt prolongation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0954-7894.2002.01314.X

Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0954-7894.2002.01314.X

A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0954-7894.2002.01314.X

SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0954-7894.2002.01314.X

Mutations in the hminK gene cause long QT syndrome and suppress IKs function

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0954-7894.2002.01314.X

MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0954-7894.2002.01314.X

A distinct potassium channel polypeptide encoded by the Drosophila eag locus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0954-7894.2002.01314.X

A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0954-7894.2002.01314.X

HERG, a primary human ventricular target of the nonsedating antihistamine terfenadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0954-7894.2002.01314.X

Blockade of HERG channels expressed in Xenopus oocytes by the histamine receptor antagonists terfenadine and astemizole

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0954-7894.2002.01314.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0954-7894.2002.01314.X

QT lengthening and life-threatening arrhythmias associated with fexofenadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0954-7894.2002.01314.X

Torsade de pointes with an antihistamine metabolite: potassium channel blockade with desmethylastemizole

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0954-7894.2002.01314.X

New insights into the second generation antihistamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0954-7894.2002.01314.X

Inhibition of HERG1 K(+) channels by the novel second-generation antihistamine mizolastine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0954-7894.2002.01314.X

Cardiotoxic potential and CNS effects of first-generation antihistamines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0954-7894.2002.01314.X

Risk of developing life-threatening ventricular arrhythmia associated with tefenadine in comparison with over-the-counter antihistamines, ibuprofen and clemastine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0954-7894.2002.01314.X

A structural basis for drug-induced long QT syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0954-7894.2002.01314.X

HERG K+ channels: friend and foe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0954-7894.2002.01314.X

10.1046/J.0954-7894.2002.01314.X

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference